You are here

  • Home
  • Archive
  • Volume 13, Issue Suppl 1
  • SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?

Article Text

Article menu
Download PDFPDF
ABSTRACTS: PLENARY SESSIONS: Session 4 – Ovary and Vulva
SHOULD CA125 RESPONSE CRITERIA BE PREFERRED TO WHO CRITERIA IN THE MONITORING OF SECOND-LINE CHEMOTHERAPY (SLC) OF EPITHELIAL OVARIAN CARCINOMA (EOC)?

https://doi.org/10.1136/ijgc-00009577-200303001-00022

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.